Perception Therapeutics
Gene therapy company for inherited retinal diseases.
All edits by Miguel Almonte
Edits on 7 May, 2019
Miguel Almonte
Edits made to:
Article (+20/-20 characters)
Article
Dr. Trevor McGill received his Ph.D. from the University of Lethbridge in 2008 and subsequently joined the Casey Eye Institute at OHSU as a post doctoral fellow. In 2011, Dr. McGill joined the faculty at the Casey Eye Institute as Research Assistant Professor. Dr. McGill's lab uses both rodent and nonhuman primate models of Retinitis PigmentosaRetinitis Pigmentosa and Age-related Macular Degeneration to aid in the translation of cell-based and gene therapies for retinal degenerative disease into clinical trials.
Find more entities like Perception Therapeutics
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.